← Levosalbutamol

Patient counseling sheet

Print-ready and generated without storing patient details.

AfyaIndex · counseling handout

Levosalbutamol

Beta-2 adrenergic agonist (bronchodilator)

Prepared 24 Sep 2026

What it is used for

Bronchospasm in asthma, bronchitis, chronic bronchitis, ephysema, bronchiectasis. Clinical selection for Levosalbutamol should follow culture results where relevant, Kenya STG/EML recommendations, and the current product SmPC. Class context: Beta-2 adrenergic agonist (bronchodilator). Confirm site-specific dose, duration and monitoring before prescribing.

Warnings

Paradoxical bronchospasm. Hypokalaemia with high dose/nebs especially with steroids/diuretics/xanthines. CV disease: tachycardia/arrhythmia risk. Thyrotoxicosis caution.

Possible side effects

Tachycardia, skeletal muscle cramp, palpitation, headaches, severe emotional disturbances, resistance after prolonged use, acidosis, GI disturbances, hypokaleamia, sweat

Storage

Store as labelled. Keep out of reach of children.

No reviewed patient-education article is available. The fields shown are from the currently verified medicine record and unavailable fields are not inferred.

AfyaIndex dataset coverage